{{Rsnum
|rsid=4987852
|Gene=BCL2
|Chromosome=18
|position=63126688
|Orientation=plus
|GMAF=0.02801
|Gene_s=BCL2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 86.6 | 10.7 | 2.7
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 98.2 | 1.8 | 0.0
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 99.0 | 1.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 96.5 | 3.5 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 96.1 | 3.9 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23770605
  |Trait=Chronic lymphocytic leukemia
  |Title=Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.
  |RiskAllele=
  |Pval=8E-11
  |OR=1.41
  |ORtxt=[NR]
  |OA=1
}}

{{PMID Auto
|PMID=22037783
|Title=Prognostic impact of polymorphisms in the MYBL2 interacting genes in breast cancer.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}